» Articles » PMID: 2646319

Systemic Senile Amyloidosis. Identification of a New Prealbumin (transthyretin) Variant in Cardiac Tissue: Immunologic and Biochemical Similarity to One Form of Familial Amyloidotic Polyneuropathy

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1989 Mar 1
PMID 2646319
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Isolated amyloid fibrils from three cases of systemic senile amyloidosis (SSA) contained subunit proteins with molecular masses of 14 (10-20%), 10-12 (60-80%), and 5-6 kD (5-10%) when fractionated under reducing and dissociating conditions. This grouping was identical to that seen in SKO, a case of familial amyloidotic polyneuropathy (FAP) studied earlier. Amino acid sequencing confirmed that SSA subunit proteins were in fact prealbumin (transthyretin). Complete sequence analysis of one SSA preparation revealed the presence of a new variant Pa (TTr) molecule with a single amino acid substitution of isoleucine for valine at position 122. Further studies used an antiserum specific for SKO IV, a subunit protein of SKO previously shown to correspond to carboxy-terminal 78 residues (positions 49-127) of (TTr). Anti-SKO IV reacted with SSA in tissue at equivalent dilutions to anti-Pa (TTr) and with the 10-12-kD fraction of SSA on Western blots; reactivity was blocked by SKO IV, but not by Pa (TTr). SSA is a form of systemic amyloidosis caused by tissue deposition of Pa (TTr) and its fragments, with shared conformational or subunit antigenicity to at least one form of FAP. Identification of a new variant Pa (TTr) molecule in one case suggests further that SSA may be a genetically determined disease expressed late in life.

Citing Articles

Uneven burden of cardiac amyloidosis in people of African descent - global imbalance in resources and access.

Madu E, Mezue K BMC Glob Public Health. 2024; 1(1):15.

PMID: 39681929 PMC: 11622854. DOI: 10.1186/s44263-023-00016-3.


Clinical Penetrance of the Transthyretin V122I Variant in Older Black Patients With Heart Failure: The SCAN-MP (Screening for Cardiac Amyloidosis With Nuclear Imaging in Minority Populations) Study.

Madhani A, Sabogal N, Massillon D, Paul L, Rodriguez C, Fine D J Am Heart Assoc. 2023; 12(15):e028973.

PMID: 37486082 PMC: 10492994. DOI: 10.1161/JAHA.122.028973.


Association of the transthyretin variant V122I with polyneuropathy among individuals of African ancestry.

Parker M, Damrauer S, Tcheandjieu C, Erbe D, Aldinc E, Hawkins P Sci Rep. 2021; 11(1):11645.

PMID: 34079032 PMC: 8172853. DOI: 10.1038/s41598-021-91113-6.


Association of the V122I Hereditary Transthyretin Amyloidosis Genetic Variant With Heart Failure Among Individuals of African or Hispanic/Latino Ancestry.

Damrauer S, Chaudhary K, Cho J, Liang L, Argulian E, Chan L JAMA. 2019; 322(22):2191-2202.

PMID: 31821430 PMC: 7081752. DOI: 10.1001/jama.2019.17935.


Cardiac Amyloid - An Update.

Dungu J Eur Cardiol. 2018; 10(2):113-117.

PMID: 30310435 PMC: 6159448. DOI: 10.15420/ecr.2015.10.2.113.


References
1.
FRANKLIN E, Zucker-Franklin D . Antisera specific for human amyloid reactive with conformational antigens. Proc Soc Exp Biol Med. 1972; 140(2):565-8. DOI: 10.3181/00379727-140-36504. View

2.
Frederiksen T, GOTZSCHE H, HARBOE N, KIAER W, MELLEMGAARD K . Familial primary amyloidosis with severe amyloid heart disease. Am J Med. 1962; 33:328-48. DOI: 10.1016/0002-9343(62)90230-9. View

3.
Wright J, CALKINS E . Amyloid in the aged heart: frequency and clinical significance. J Am Geriatr Soc. 1975; 23(3):97-103. DOI: 10.1111/j.1532-5415.1975.tb00968.x. View

4.
Pepys M, Dash A . Isolation of amyloid P component (protein AP) from normal serum as a calcium-dependent binding protein. Lancet. 1977; 1(8020):1029-31. DOI: 10.1016/s0140-6736(77)91260-0. View

5.
Westermark P, Natvig J, Johansson B . Characterization of an amyloid fibril protein from senile cardiac amyloid. J Exp Med. 1977; 146(2):631-6. PMC: 2180768. DOI: 10.1084/jem.146.2.631. View